WO2006121710A3 - Bladder cancer biomarkers and uses thereof - Google Patents
Bladder cancer biomarkers and uses thereof Download PDFInfo
- Publication number
- WO2006121710A3 WO2006121710A3 PCT/US2006/016816 US2006016816W WO2006121710A3 WO 2006121710 A3 WO2006121710 A3 WO 2006121710A3 US 2006016816 W US2006016816 W US 2006016816W WO 2006121710 A3 WO2006121710 A3 WO 2006121710A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bladder cancer
- biomarkers
- polynucleotides
- proteins
- identification
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008510130A JP2008539728A (en) | 2005-05-02 | 2006-05-02 | Bladder cancer biomarker and use thereof |
EP06784380A EP1882048A2 (en) | 2005-05-02 | 2006-05-02 | Bladder cancer biomarkers and uses thereof |
CA002607243A CA2607243A1 (en) | 2005-05-02 | 2006-05-02 | Bladder cancer biomarkers and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67692105P | 2005-05-02 | 2005-05-02 | |
US60/676,921 | 2005-05-02 | ||
US72905605P | 2005-10-21 | 2005-10-21 | |
US60/729,056 | 2005-10-21 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006121710A2 WO2006121710A2 (en) | 2006-11-16 |
WO2006121710A9 WO2006121710A9 (en) | 2007-03-01 |
WO2006121710A3 true WO2006121710A3 (en) | 2009-04-16 |
Family
ID=37397081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/016816 WO2006121710A2 (en) | 2005-05-02 | 2006-05-02 | Bladder cancer biomarkers and uses thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070134681A1 (en) |
EP (1) | EP1882048A2 (en) |
JP (1) | JP2008539728A (en) |
CA (1) | CA2607243A1 (en) |
TW (1) | TW200716764A (en) |
WO (1) | WO2006121710A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288369B2 (en) * | 2006-06-27 | 2012-10-16 | University Of South Florida | Delta-tocotrienol treatment and prevention of pancreatic cancer |
CN101587125B (en) * | 2008-05-21 | 2013-07-24 | 林标扬 | High expression cancer marker and low expression tissue organ marker kit |
JP2010233542A (en) * | 2009-03-31 | 2010-10-21 | Kanazawa Univ | Primer set and probe capable of distinguishing and amplifying two kinds of splicing variants of rage gene |
CN104483488A (en) * | 2009-08-28 | 2015-04-01 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2011085163A2 (en) * | 2010-01-08 | 2011-07-14 | The Regents Of The University Of California | Protein markers for lung cancer detection and methods of using thereof |
US20110301110A1 (en) * | 2010-06-03 | 2011-12-08 | Aucagne Romain | TRIM33 (TIF1gamma) AS A NEW DIAGNOSTIC MARKER OF CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) |
US9151769B2 (en) * | 2010-07-02 | 2015-10-06 | Idexx Laboratories, Inc. | Automated calibration method and system for a diagnostic analyzer |
US9725494B2 (en) * | 2013-05-17 | 2017-08-08 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Soluble CD27 (sCD27) and the use thereof |
CN114686607B (en) * | 2020-12-31 | 2023-09-26 | 深圳华大生命科学研究院 | Application of corynebacteria as urine microorganism marker in preparation of related detection products for detecting bladder cancer |
CN114758773A (en) * | 2022-05-25 | 2022-07-15 | 四川大学华西医院 | Bladder cancer immunotherapy biomarker, immune risk model and application of immune risk model |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040014059A1 (en) * | 1999-01-06 | 2004-01-22 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
-
2006
- 2006-05-01 TW TW095115476A patent/TW200716764A/en unknown
- 2006-05-02 WO PCT/US2006/016816 patent/WO2006121710A2/en active Application Filing
- 2006-05-02 EP EP06784380A patent/EP1882048A2/en not_active Ceased
- 2006-05-02 CA CA002607243A patent/CA2607243A1/en not_active Abandoned
- 2006-05-02 US US11/417,354 patent/US20070134681A1/en not_active Abandoned
- 2006-05-02 JP JP2008510130A patent/JP2008539728A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040014059A1 (en) * | 1999-01-06 | 2004-01-22 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
Also Published As
Publication number | Publication date |
---|---|
TW200716764A (en) | 2007-05-01 |
EP1882048A2 (en) | 2008-01-30 |
US20070134681A1 (en) | 2007-06-14 |
WO2006121710A2 (en) | 2006-11-16 |
WO2006121710A9 (en) | 2007-03-01 |
JP2008539728A (en) | 2008-11-20 |
CA2607243A1 (en) | 2006-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006086242A3 (en) | Mild osteoarthritis biomarkers and uses thereof | |
WO2006121710A3 (en) | Bladder cancer biomarkers and uses thereof | |
WO2006020269A3 (en) | Biomarkers of neurodegenerative disease | |
WO2006055524A3 (en) | Biomarkers for diagnosing schizophrenia and bipolar disorder | |
WO2005113831A3 (en) | Biomarkers for multiple sclerosis and methods of use thereof | |
WO2014026768A8 (en) | Colorectal cancer markers | |
WO2008118877A3 (en) | Method of diagnosing, classifying and treating endometrial cancer and precancer | |
WO2005114190A3 (en) | Methods of identifying biomarkers | |
WO2007047408A3 (en) | Promac signature application | |
WO2008079269A3 (en) | Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom | |
WO2012143481A3 (en) | Prostate cancer markers | |
WO2005044990A3 (en) | Use of differentially expressed nucleic acid sequences as biomarkers for cancer | |
WO2008150496A3 (en) | Assay for sensitivity to chemotherapeutic agents | |
WO2008105797A3 (en) | Polynucleotides encoding novel pcsk9 variants | |
WO2007000320A3 (en) | Method for diagnosing rheumatic diseases | |
WO2006029176A3 (en) | Cancer-testis antigens | |
WO2006034328A3 (en) | Wnt proteins and detection and treatment of cancer | |
WO2007146668A3 (en) | Use of imp3 as a prognostic marker for cancer | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
WO2009019370A3 (en) | Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer | |
WO2008019052A3 (en) | Methods and compositions for identifying biomarkers | |
WO2006036179A3 (en) | Frizzled proteins and detection and treatment of cancer | |
WO2006036175A3 (en) | Wnt proteins and detection and treatment of cancer | |
WO2005124358A3 (en) | Diagnosis and treatment of siglec-6 associated diseases | |
WO2007094027A8 (en) | Methods for the diagnosis of proliferative and/or conformational diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680024055.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2607243 Country of ref document: CA Ref document number: 2008510130 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006784380 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |